Why Spark’s CEO says 2017 may be a ‘historic year’ for his gene therapy company – Philadelphia Business Journal
Philadelphia Business Journal |
Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company
Philadelphia Business Journal Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children … Spark Therapeutics Reports 2016 Financial Results and Business Highlights |
